Related Experiment Video

Updated: Jan 18, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K

A Novel Case of Indolent T-Lymphoblastic Proliferation in Metastatic High-Grade Serous Adenocarcinoma

Mia Dahl Sørensen1,2, Anja Ør Knudsen3, Michael Boe Møller1,2

  • 1Department of Pathology, Odense University Hospital, Odense, Denmark.

International Journal of Laboratory Hematology
|September 10, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
T‐lymphoblastflow cytometryindolent T‐lymphoblastic proliferationleukemialymphoma

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.2K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.7K

Related Experiment Videos

Last Updated: Jan 18, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.2K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.7K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Metastasis02:30

Metastasis

6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K

Articles linked to this work by shared authors, journal, and citation graph.

AI-based delineation based on clinical data in MR-guided brachytherapy for cervical cancer reduces delineation time - A prospective paired trial.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026

Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.

Blood advances·2025

Monitoring ctDNA in aggressive B-cell lymphoma: a prospective correlative study of ctDNA kinetics and PET-CT metrics.

Blood advances·2025

NSGO-FANDANGO/ENGOT-EN1: A randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer.

Gynecologic oncology·2025

Liquid Biopsy for Enhanced Specificity in Identifying Somatic Mutations in Aggressive Non-Hodgkin Large B-Cell Lymphoma: A Comparative Study of Cell-Free DNA and Formalin-Fixed Paraffin-Embedded Tissue.

International journal of laboratory hematology·2025

A Case-Driven Multi-Omics Analysis for Longitudinal Ibrutinib Response Evaluation of Patients With Chronic Lymphocytic Leukemia.

European journal of haematology·2025

Performance Evaluation of an Artificial Intelligence-Assisted Digital Morphology System for Bone Marrow Aspirate Examination.

International journal of laboratory hematology·2026

Smoking-Related Distortion of Haemoglobin Concentration May Alter Anaemia Classification and Population Burden Estimates.

International journal of laboratory hematology·2026

Comprehensive Multicenter Evaluation of an AI-Based Deep Learning System for Automated Blood Cell Classification and Morphologic Analysis.

International journal of laboratory hematology·2026

Comparison of the HemoScreen Point-Of-Care Haematology Analyser With Sysmex XN, Beckman Coulter DxH 560 and HORIBA Yumizen H550 in Patients With Abnormal Blood Counts.

International journal of laboratory hematology·2026

Differentiating β-Thalassaemia From Iron Deficiency: Performance and Cut-Off Dependency of More Than 40 Red Cell Discrimination Indices in a Large German Cohort.

International journal of laboratory hematology·2026

Adding-On Wisely: Hematopathology Reflective Testing in Canada.

International journal of laboratory hematology·2026

The soluble HLA repertoire captures neoantigenic, cryptic, and tumour-associated peptides in melanoma.

Molecular & cellular proteomics : MCP·2026

Inflammatory Breast Cancer-The Evolution of Diagnosis and Modern Clinical Management.

JCO oncology practice·2026

Engineering Subcutaneous Ectopic Tertiary Lymphoid Structures as Personalized Immune-Activation Niches for Cancer Immunotherapy.

ACS applied bio materials·2026

Exosomes derived from itaconate-treated macrophages promote epithelial-mesenchymal transition, migration, and invasion in MCF-7 breast cancer cells.

Medical oncology (Northwood, London, England)·2026

Vibostolimab Coformulated with Pembrolizumab Plus Chemotherapy as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer.

Targeted oncology·2026

Tumor-Associated Mast Cells Drive Immunosuppression and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4-mediated Regulatory T-Cell Recruitment.

Journal of biochemical and molecular toxicology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us